Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
Sign Up to like & getrecommendations! Published in 2024 at "Hepatology Research"
DOI: 10.1111/hepr.14139
Abstract: Atezolizumab/bevacizumab is a first‐line therapy for unresectable hepatocellular carcinoma (HCC). Among several adverse events, grade ≥2 proteinuria is considered a significant adverse event that may cause bevacizumab interruption. Studies have shown that proteinuria might predict… read more here.
Keywords: unresectable hepatocellular; hepatocellular carcinoma; bevacizumab; improved prognosis ... See more keywords
IL17RB and IL17REL Expression Are Associated with Improved Prognosis in HPV-Infected Head and Neck Squamous Cell Carcinomas
Sign Up to like & getrecommendations! Published in 2023 at "Pathogens"
DOI: 10.3390/pathogens12040572
Abstract: Changes in the cellular secretome are implicated in virus infection, malignancy, and anti-tumor immunity. We analyzed the association between transcriptional signatures (TS) from 24 different immune and stromal cell types on the prognosis of HPV-infected… read more here.
Keywords: cell; hnscc patients; improved prognosis; prognosis hpv ... See more keywords